Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin.

[1]  M. Banerjee,et al.  Prognostic implications of a positive apical margin in radical prostatectomy specimens. , 1998, The Journal of urology.

[2]  S. Schild.  Radiation therapy after prostatectomy: now or later? , 1998, Seminars in radiation oncology.

[3]  D. Bostwick,et al.  Pathologic classification of prostate carcinoma , 1998, Cancer.

[4]  D. Bostwick,et al.  Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. , 1997, Urology.

[5]  A. Partin,et al.  Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.

[6]  H. Levin,et al.  Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. , 1997, International journal of radiation oncology, biology, physics.

[7]  T. Wiegel,et al.  Re: Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. , 1997, The Journal of urology.

[8]  David G. Bostwick,et al.  Urologic Surgical Pathology , 1997 .

[9]  S. Levitt,et al.  Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow‐up , 1996 .

[10]  H. Levin,et al.  Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. , 1996, Urology.

[11]  D. Bostwick,et al.  Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. , 1996, The Journal of urology.

[12]  M. Soloway,et al.  Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. , 1996, Urology.

[13]  L. Sullivan,et al.  Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. , 1996, The Journal of urology.

[14]  V. Hárs,et al.  Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. , 1996, Urology.

[15]  S. Groshen,et al.  Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. , 1996, The Journal of urology.

[16]  H. Zincke,et al.  Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy. , 1995, Urology.

[17]  M. Anscher,et al.  Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update. , 1995, International journal of radiation oncology, biology, physics.

[18]  A. D'Amico,et al.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.

[19]  J. Oesterling,et al.  Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.

[20]  M. Frydenberg,et al.  Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. , 1993, Urology.

[21]  A. Zietman,et al.  Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure. , 1993, Urology.

[22]  Z. Petrovich,et al.  Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings. , 1993, The Journal of urology.

[23]  R. Mark,et al.  Postoperative radiation therapy after radical prostatectomy for prostate carcinoma , 1992, Cancer.

[24]  J. Moul,et al.  Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. , 1990, The Journal of urology.

[25]  R. Vessella,et al.  The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. , 1990, The Journal of urology.

[26]  W. Catalona,et al.  Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. , 1990, The Journal of urology.

[27]  J. Moul,et al.  Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. , 1990, The Journal of urology.

[28]  J. Smith,et al.  Postoperative radiation therapy for pathologic stage C prostate cancer. , 1987, International journal of radiation oncology, biology, physics.

[29]  M. Pilepich,et al.  Postoperative irradiation in carcinoma of the prostate. , 1984, International journal of radiation oncology, biology, physics.

[30]  F. Richard,et al.  Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. , 1998, The Journal of urology.

[31]  J. Forman,et al.  Therapeutic radiation in patients with a rising post-prostatectomy PSA level. , 1998, Oncology.

[32]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[33]  A. Zietman,et al.  Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[34]  R. B. Smith,et al.  Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles. , 1992, Urology.

[35]  P. Lange,et al.  Radiation therapy as adjuvant treatment after radical prostatectomy. , 1988, NCI monographs : a publication of the National Cancer Institute.

[36]  M. Hafermann,et al.  Adjuvant radiotherapy following radical prostatectomy: results and complications. , 1986, The Journal of urology.